Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IRBS

IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:IRBS
DateTimeSourceHeadlineSymbolCompany
05/24/20114:28PMEdgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
05/16/20112:11PMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
03/31/201111:54AMEdgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
03/10/20114:29PMEdgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
11/22/20103:12PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
11/12/20107:27AMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
10/28/20108:00AMGlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University CollaborationUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
10/01/20103:37PMEdgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
09/08/20106:00AMGlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/31/20101:21PMGlobeNewswire Inc.ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for InUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/25/20108:00AMGlobeNewswire Inc.University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/23/20104:15PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/13/20103:12PMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/05/20107:27AMMarketwired/ CORRECTION - ImmuneRegen BioSciencesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/04/20106:00AMMarketwiredImmuneRegen BioSciences Completes Successful Reduction of DebtUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
07/26/20105:01AMEdgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
05/24/20102:40PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
05/17/201010:51AMEdgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/30/20104:17PMEdgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/27/20107:00AMMarketwiredImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen MeUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/21/20107:00AMMarketwiredImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead IndicaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/19/201012:00PMMarketwiredImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic PlanningUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/15/20103:20PMEdgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/01/20103:01PMEdgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
03/04/20107:00AMMarketwiredImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary FiUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
02/10/20107:00AMMarketwiredFred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/27/20107:00AMMarketwiredNational Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/26/20101:54PMMarketwiredIR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active CompoundUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/05/20107:00AMMarketwiredImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic InfluenzaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
12/24/20097:00AMMarketwiredImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development ContinuesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
 Showing the most relevant articles for your search:USOTC:IRBS